Figure 1. Different Modules on the Armadillo/␤-catenin Protein
The middle domain contains 13 imperfect repeats that in different combinations can interact with APC, TCF/Lef1, or E-cadherin. The unique amino-terminal domain can be phosphorylated, which is correlated with down-regulation of Arm. Those residues are sometimes found to be mutated in colon carcinoma or melanoma cell of TCF by Brunner et al. (1997 These mutant phenotypes show that TCF is in the wg make it ideally suitable to perform such an integrating function, and it may do so by using Arm as an element in pathway. But are any of the wg target genes directly activated by the Arm-TCF complex? wg controls the the reconfiguration of transcriptional complexes rather than as a direct activator. expression of many different genes, in a tissue-specific manner, but very few of these target genes and their There are of course many questions remaining. What are the transcriptional activators used by TCFs in other promoters have been analyzed in sufficient detail. One notable exception is the detailed and long-standing cells, including the mammalian lymphocytes where these proteins were originally found? How is Arm dianalysis of the function of Ubx, a homeobox gene, in the fly midgut by Bienz and colleagues (Bienz, 1994) .
rected to its different partners, E-cadherin, or TCF, or yet others? And how does Arm enter the nucleus? It They had found previously that expression of Ubx in mesodermal cells lining the Drosophila gut is controlled is a fairly big protein (110 kDa) but it lacks a nuclear localization signal. Possibly, cytoplasmic Arm binds to by wg and dpp, in an intricate way involving autoregulation mediated by these secreted signals. Both wg and newly synthesized TCF and is carried on to the nucleus. One particular experiment in Drosophila by Riese et al. dpp are required for Ubx expression (Figure 2 ). By fine mapping a control element on the Ubx promoter, Riese (1997) gives a hint in this direction: overexpression of Lef-1 causes phenotypes similar to ectopic Wg effects et al. (1997) have now found a wg-responsive element (WRE) adjacent to a dpp-responsive element (DRE, a and leads to ectopic expression of a reporter construct containing the Lef-1 binding site. Importantly, these ef-CREB-responsive element). The WRE contains a perfect TCF binding site and can be activated by ectopic exfects are independent of wild-type wg function (removing wg genetically has no consequence). This may argue pression of a mouse TCF (Lef-1 was used here). In vivo tests for activation of reporter constructs point to a that an excess of newly made TCF, while still cytoplasmic, picks up Arm, prevents it from degradation and requirement for the dpp element to be immediately adjacent; the WRE by itself is not sufficient for activation by carries it on to the nucleus to activate gene expression (Figure 2 ). TCF. The requirement for close proximity of the dppresponsive element and the TCF binding site is reminisDuring Wg/Wnt signaling, the critical step in activating Arm to become a transcription factor may merely be cent of earlier work showing that TCFs play an architectural role in activating gene expression. By affecting an increase in cytoplasmic concentration of free Arm molecules. This signal from the Wg receptor is thought DNA bending, TCFs may bring together several transcription factors (Giese et al., 1992) . Obviously, a combito be relayed by the protein kinase Zw-3 (the Drosophila homolog of GSK-3␤; Figure 2 ) (Siegfried et al., 1994) . In natorial mechanism of target gene activation-through adjacent enhancers that are both required-provides a cells not exposed to a Wnt signal, the Zw-3 kinase is active and may phosphorylate Arm directly. The amino simple explanation for the tissue specificity for wg or dpp signaling. There are many other examples where terminus of Arm contains several Zw-3 substrate sites that can become phosphorylated. Eliminating these these two signals cooperate, and in cases where wg and dpp are not acting together, wg may team up with sites stabilizes Arm sufficiently to activate it (Figure 1 ).
Based mostly on genetic interactions, but also on biofunction of APC in Drosophila. A fly APC homolog was recently identified, but based on its expression and a chemical data, the wg signal would inactivate Zw-3, leading to an increase in Arm which would then be availpreliminary mutant analysis, APC does not participate in Wg signaling (Hayashi et al., 1997) . This assumes that able for binding to TCF (Figure 2 ).
Wg Signaling Components in Human Cancer
the gene is not redundant or maternally provided, but it points to interesting alternative pathways. Further geAs found in mammalian cells, the interaction between Zw-3 and Arm is actually more complex. There is yet netic tests of this signaling system in cancer cells, flies, and worms, combined with cell biological experiments, another player in regulating Arm, the tumor suppressor gene APC. The APC protein binds to Arm and accelerwill undoubtedly add more to this rapidly developing story. ates Arm turnover. APC also binds to Zw-3 and is in fact a better substrate for Zw-3 than Arm. A complex Selected Reading between these three proteins may keep Arm levels low (Figure 2) (Rubinfeld et al., 1996) . APC, E-cadherin, and Behrens, J., Von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., TCF can all bind to the middle domain of Arm, the part Grosschedl, R., and Birchmeier, W. (1996) . Nature. 382, 638-642. that contains a stretch of 13-fold repeated sequences, Bienz, M. (1994) . Trends Genet. 10, 22-26. but each partner binds to a specific subset of these Brunner, E., Peter, O., Schweizer, L., and Basler, K. (1997) . Nature repeats (Figure 1) . Possibly, there is some competition 385, 829-833. for binding, and binding by one or the other partners is Clevers, H.C., and Grosschedl, R. (1996) . Immunol. Today 17, subject to some regulation.
336-343.
APC traces its history to tumors found in familial colon Giese, K., Cox, J., and Grosschedl, R. (1992) . Cell 69, [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] carcinomas; it is a tumor suppressor gene that is deleted incapable of blocking target gene expression. (1994) . Nature 367, [80] [81] [82] [83] These experiments provide a plausible explanation of Nü sslein-Volhard, C., and Wieschaus, E. (1980) . Nature 287, how loss of APC can activate gene expression and lead 795-801. to cell transformation (although no target genes in onco- Orsulic, S., and Peifer, M. (1996 ). J. Cell Biol. 134, 1283 -1300 genesis are known). A surprise came when Morin et Riese, J., Yu, X., Munnerlyn, A., Eresh, S., Hsu, S.-C., Grosschedl, al. (1997) found several colon carcinoma cell lines with R., and Bienz, M. (1997) . Cell 88, [777] [778] [779] [780] [781] [782] [783] [784] [785] [786] [787] normal levels of wild-type APC but nevertheless disRobbins, P.F., El-Gamil, M., Li, Y.F., Kawakami, Y., Loftus, D., Applaying strong expression of these reporter constructs).
pella, E., and Rosenberg, S.A. (1996) . J. Exp. Med. 183, 1185 -1192 It appeared that Arm in those cells had found another Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., and Poway to escape from APC control: by mutations in its lakis, P. (1996) . Science 272, 1023 Science 272, -1026 own gene. These mutations are also present in several Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., and melanoma (Robbins et al., 1996; Rubinfeld et al., 1997) Polakis, P. (1997) . Science 275, 1790 Science 275, -1792 and are of a special class: they eliminate specific amino Siegfried, E., Wilder, E.L., and Perrimon, N. (1994) . Nature 367, acids in the amino-terminal domain of the protein, in 76-80. particular residues that become phosphorylated prior van de Wetering, M., Cavallo, R., Dooijes, D., van Beest, M., van Es, to the proteolytic down-regulation of Arm (Figure 1 ). J., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., Peifer, M., Mortin, M., and Clevers, H. (1997) . Cell 88, [789] [790] [791] [792] [793] [794] [795] [796] [797] [798] [799] Hence, Arm can turn into an oncogene in its own right. A question that remains, however, is whether TCF is required for cell transformation by loss of APC or mutations in Arm. A testable prediction of the models emerging from these papers is that a dominant negative TCF should revert the transformed phenotype.
It is now fairly common to find signal transduction pathways conserved in evolution or to find components in these critical growth-controlling mechanisms mutated in tumors. Nonetheless, the discoveries summarized here form yet another spectacular and exciting example of these principles. Yet, one piece is missing: a genetic
